SOX2 and glioma: Similarly, targeted therapies for immune checkpoint blockade were found to be effective against tumors, whereas glial tumors in children require the SOX2 transcription factor, an embryonic neural stem cell antigen that is strongly implicated in the biology of glioma-initiating cells and acts as an antigenic molecule in anticancer immunity [21, 22].